Traitements3programmes
Essais1liés
Publications4liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
Partial Rebreathing DeviceA prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura Migraine Non applicable À vérifier United States, Germany À vérifier
Sham breathing deviceA prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura Migraine Non applicable À vérifier United States, Germany À vérifier
Partial Rebreathing DeviceA prospective, multi-centre, randomized, double-blind, sham-controlled, parallel-group, group-sequential study to investigate safety and effectiveness of the Rehaler partial rebreathing device, in adults suffering from migraine with aura Migraine Non applicable À vérifier United States, Germany À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Partial Rebreathing Device Migraine Non applicable NCT05546385 PAREMA1 — PArtial REbreathing for Migraine With Aura 1 TERMINATED

Publications

4
MoléculeIndication / populationTitreJournalDate
Sham breathing device Modulating autonomic nervous system activity with transcutaneous auricular vagus nerve stimulation in Parkinson's disease: a proof of concept study. Frontiers in neuroscience
Sham breathing device A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial. Journal of Alzheimer's disease : JAD
Sham breathing device Impact of respiratory muscle training on sleep disordered breathing in people with tetraplegia: a sub-analysis of a randomised controlled trial. Spinal cord
Partial Rebreathing Device Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double-blind, randomized, controlled trial (PAREMA1). Headache